vasodilatation in the brachial artery, and experiments with NO donors and NO synthase inhibitors indicate that the PAT signal, in part, is NO-dependent. 8 In severe acute conditions such as sepsis and major surgical operations, measurements of endothelial function might be applicable in prospective risk stratification of patients. 9 10 Measurement of peripheral vasodilator response as an expression of endothelial dysfunction correlate with outcome, 10 and it has been shown that the PAT signal can be used as a user-independent risk factor for development of late complications after an acute coronary syndrome. 11 In SAH patients, the measurement might help identify patients at risk for developing life-threatening cerebral vasospasm. We hypothesized that the results of early measurements of endothelial function with PAT correlate with other indices for the development of cerebral vasospasm, that is, transcranial Doppler (TCD) measurements of velocities in large cerebral arteries, and plasma concentrations of nitrite/nitrate, S-100B, arginine, and asymmetric dimethylarginine (ADMA). We also tested whether measurements with PAT correlate with 30 day mortality after SAH.
Methods

Subjects
Forty-eight patients admitted to the neurointensive care unit at the Copenhagen University Hospital between February 2011 and December 2011 with spontaneous aneurysmal SAH verified by computed tomography (CT) were studied prospectively in the 30 days after the initial rupture of the aneurysm. The presence of an aneurysm was confirmed by CT angiography, digital subtraction angiography, or during surgery. Exclusion criteria included prior spontaneous SAH, age ,18, or pending cerebral herniation. Control subjects (n¼23) were recruited with no history or clinical signs of cancer, diabetes mellitus, arterial hypertension, cerebral disease, or current smoking. The study population is a subpopulation of a previously published study; of which, we have published serum nitrite/nitrate concentrations and plasma arginine:ADMA ratios. 12 
Ethics
Written informed consent was obtained from each participant or by the nearest relative and the patient's general practitioner. The study protocol was approved by the Regional Ethical Committee of Copenhagen Region (H-3-2010-136).
Data acquisition
Data on prior medical history and medicine consumption were obtained from the SAH patients or their nearest relatives. In SAH patients, measurements were grouped into five consecutive intervals with 3 days in each interval: days 0 -2, days 3-5, days 6-8, days 9-11, and days 12-14. The use of vasoactive drugs (remifentanil, propofol, and/or norepinephrine) was noted in each testing period.
Measurement of peripheral endothelial function
Peripheral endothelial function was assessed by non-invasive digital pulse amplitude tonometry by the use of an EndoPAT 2000 (Itamar Medical Ltd, Caesarea, Israel). The system collects data digitally, removes noise, and performs semi-automatic calculation of the post-occlusion/pre-occlusion ratio, the reactive hyperaemia index (RHI). The device consists of two fingertip probes measuring volume changes in relation to arterial pulsation. An air-filled chamber in the fingertip probe provides a uniform pressure preventing the venoarterial vasoconstrictor reflex. Measurements were performed on both arms simultaneously to account for systemic changes in vascular tone.
The SAH subjects underwent bedside EndoPAT measurements in the supine position at study inclusion which was carried out as soon as possible after SAH, and then four more times within a 14 day period. After a 5 min equilibration period, a cuff was rapidly inflated on one upper arm up to 200 mm Hg, or to 50 mm Hg above systolic arterial pressure, in 5 min according to recommendations for maximal response. 13 Reactive hyperaemia was induced when the cuff was released. A similar measurement was performed in the control subjects after 15 min of sitting at rest. 
Cerebral vasospasm
Laboratory assays
Blood samples were collected immediately before the EndoPAT measurements and were stored at 2808C until analysis. Samples for measurement of nitrite/nitrate were centrifuged through a 30 kDa micropore filter (Nanosep 30k Omega, Pall Corp., Ann Arbor, MI, US) before duplicate analysis with a commercially available NO x detection kit based on the Griess reaction (cat. 780001, Nitrite/Nitrate Colorimetric Assay Kit, Cayman Chemicals, Ann Arbor, MI, USA). Concentration of S-100B was measured by ELISA (Roche Diagnostics, Mannheim, Germany). Arginine and ADMA were measured with high performance liquid chromatography as previously described. 12 Briefly, solid phase extraction of plasma samples (Oasis MCX columns, Waters, Milford, MA, USA) was followed by derivatization of basic amino acids with o-phthaldialdehyde to form fluorescent compounds. These were separated on a Symmetry C18 column (Waters) with a flow rate of 1.1 ml min 21 (Shimadzu LC-20AD pumps, Kyoto, Japan) and measured on a fluorescence detector (Shimadzu RF-20A). Monoethyl arginine was used as the internal
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standard. The peak area was quantified manually on a computer with Empower 2.0 software (Waters).
Statistical analysis
Statistical analysis was performed with R-2.15.1 software for Mac 15 and additional packages nlme 16 and ggplot2 attached. 17 Student's t-test was used to compare RHI between control and SAH subjects at baseline. Longitudinal measurements of variables were analysed using a linear mixed effects models (nlme package) to account for within-subject correlation of serial measurements. The subject term entered the model as a random effect on the intercept. Model assumptions were checked by residual plots. Values are given as mean (SD).
Results
Data from 48 SAH patients and 23 control subjects entered the analysis. Subject characteristics are presented in Table 1 . SAH subject years range from 22 to 81. Control subject age was 37 (range 28-64) yr (P¼0.00005 compared with patients).
Body mass index (kg m 22 ) in SAH and control subjects ranged 18-34 and 18-26, respectively (P¼0.18). Notable characteristics of this group of SAH subjects are a higher than usual prevalence of female sex and smoking. Aneurysms in the anterior complex or the middle cerebral artery were most frequent (Table 1) , which is comparable with previous findings in a Danish population. 18 The 30 day mortality was 15% (Table 1) .
Measurements with EndoPAT were feasible in almost all subjects. All five planned EndoPAT measurements were not performed in all subjects. In 33 of the 48 subjects, it was possible to perform an EndoPAT measurement days 0-2. Reasons for not being measured five times were late hospitalization, death before day 14, transfer to another hospital or early discharge, and inability to cooperate. Only two subjects were unable to cooperate on all five occasions. In one control subject, it was impossible to obtain a pulse wave reading.
The RHI in control subjects was 1.81 (0.37). In SAH subjects, EndoPAT measurements increased by 0.24 (P mixed-model t-test ¼0.02, CI 95 : 0.04-0.44) from days 0-2 to days 3-5 and remained stable thereafter ( Table 2) . The difference between days 0-2 and days 6-8 was 0.23 (P mixed-model t-test ¼0.024, CI 95 : 0.03 -0.43). The RHI in control subjects was 0.15 higher than RHI days 0-2 in SAH subjects (P t-test ¼0.25, CI 95 : 20.1 to 0.38); the difference diminished to 20.05 when comparing controls with RHI days 6-8 (P t-test ¼0.60, CI 95 : 20.29 to 0.17).
TCD measurements were performed in 36 subjects. In the remaining five subjects, TCD measurements were impossible to perform for technical reasons. Positive findings of vasospasm were found in 21 out of 36 subjects. V MCA by average tended to increase ( Table 2 ). CT-angiography was performed in 18 subjects and positive findings of vasospasm were found in 11. Overall, there was no association between V MCA and RHI.
On average, S-100B decreased through the observation period, but only values on days 10-12 were statistically different compared with baseline (Table 2 ). Plasma levels of nitrite/ nitrate remained unchanged (Table 2 ). Plasma arginine increased from days 0 to 2 onwards (Table 2) . Also ADMA slightly increased after SAH; thus, the ariginine:ADMA ratio significantly increased throughout the observation period (Table 2) .
Serial data of RHI in relation to 30 day survival, delayed neurological deficit, TCD-vasospasm, and angiographic vasospasm are presented in Figure 1 . RHI was lower on days 9-12 (CI 95 : 21.09 to 0.04, P mixed-model t-test ¼0.07) and days 13-15 (CI 95 : 21.03 to 0.07, P mixed-model t-test ¼0.08) in subjects not surviving to day 30. When RHI was averaged separately for weeks 1 and 2 after aneurysm rupture, a Cox proportional hazards model showed an association between low RHI in week 2 and mortality (P¼0.036). A decrease in RHI by 0.5 corresponded to a hazard ratio of 3.3 (CI 95 ¼1.0-11). The week 1 average RHI was not associated with mortality (P¼0.51). There were no trends towards differences in RHI according to delayed neurological deficit, TCD vasospasm, or angiographic vasospasm.
Subjects receiving remifentanil had an average RHI that was 0.21 lower compared with those not giving remifentanil (CI 95 ¼ 20.04 to 20.38, P¼0.02). There was a trend in the same direction for subjects receiving propofol (mean difference 20.16, CI 95 : 20.02 to 20.35, P¼0.08), and for subjects receiving norepinephrine (mean difference 20.16, CI 95 : 0.03 to 20.35, P¼0.09). Furthermore, the mixed effect model showed a significant association between RHI and mean arterial pressure: an increase in RHI of 1.0 was associated with an increase in mean arterial pressure of 7 mm Hg (CI 95 : 2-12 mm Hg, P mixed-model t-test ¼0.01). There were no significant differences in RHI between subjects grouped by coiling and clipping (P¼0.56 for interaction with time; P¼0.14 for main effect).
Average values of plasma arginine:ADMA ratios and serum nitrite/nitrate concentrations are plotted against RHI in Figure 2 . There was a significant correlation between subject averaged arginine:ADMA ratios and RHI (r Pearson ¼0. 43 
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Bergströ m et al. Figure 3 presents serial data of log-transformed S-100B concentrations in relation to 30 day survival, delayed neurological deficit, TCD-vasospasm, and angiographic vasospasm. In the mixed model, there was a significant interaction term between plasma levels of S-100B in relation to day after SAH and survival (P F-test ¼0.008). In non-survivors compared with survivors, values were 2.7 times higher on days 6-8 (CI 95 : 1.3-5.7, P mixed model t-test ¼0.007), 1.8 times higher days 9-11 (CI 95 : 0.9-1.8, P mixed model t-test ¼0.10), and 4.0 times higher days 12 -15 (CI 95 : 1.9-8.3, P mixed model t-test ¼0.0002). Subjects surviving to day 30 had gradually decreasing S-100B values reaching 60% of baseline at days 13 -15 (CI 95 : 0.5 -0.9, P mixed model t-test ¼0.004). Subjects with angiographic vasospasm had lower S-100B on days 3-5 and 6-8 by 0.5 (CI 95 : 0.3-0.9, P mixed model t-test ¼0.03). Subjects with delayed neurological deficit had higher S-100B than those without from days 6 to 8 and onwards. However, the ratio, 2.1, was only significantly different on days 12-15 (CI 95 : 1.2-3.8, P mixed model t-test ¼0.01). RHI was not associated with S-100B at any time after SAH.
Discussion
The main finding of this prospective observational study was that flow-mediated vasodilation in peripheral vessels is attenuated in the acute phase after SAH, suggesting that peripheral endothelial dysfunction is part of SAH pathophysiology. RHI measured by fingertip arterial tonometry correlated well with arginine:ADMA ratio but not with circulating levels of nitrite/nitrate or with well-known indices of disease severity after SAH, that is, plasma S-100B and V MCA . We used a non-invasive EndoPat 2000 device for repeated evaluation of peripheral endothelial dysfunction expressed as an RHI value. 8 The method has good agreement with measurements of flow-mediated vasodilation in the brachial artery. 8 19 20 Studies in surgical patients 10 and patients with cardiac failure 8 11 have demonstrated that assessment of peripheral endothelial function by RHI is useful for prediction of cardiovascular adverse effects. To our knowledge, the current study is the first to report measurements with fingertip arterial tonometry after SAH. Endothelial dysfunction has been frequently observed after ischaemic stroke. 21 -25 In a recent study, Scherbakov and colleagues 26 demonstrated impaired RHI response in the first 5 days after stroke in the territory of the middle cerebral artery. In line with this, we found that endothelial function is impaired in the first days after SAH. The consecutive measurements in the current study, however, showed that RHI, on average, improved thereafter. Notably, in patients who deceased before day 30, RHI did not improve and values tended to be lower compared with survivors. In addition, there was an association between low RHI in the second week after aneurysm rupture and mortality. The significance of these findings has to be tested in larger studies. ADMA, an endogenous inhibitor of nitric oxide synthases, is a marker of vascular dysfunction and increased values have been associated with mortality in cardiovascular disease. 27 -29 Circulating levels of ADMA have been found to increase after SAH. Recently, we reported that low values of the arginine:ADMA ratio are associated with mortality in SAH patients. 12 The current study extends these data by demonstrating a positive correlation between values of RHI and the arginine:ADMA ratio. This was also observed in stroke patients in whom a diminished arginine:ADMA ratio was associated with reduced RHI. 26 Thus, a similar mechanism could be active after aneurysmal SAH by which detrimental effects of ADMA contribute to impairment of endothelial function. The present data suggest that RHI after SAH is neither associated with TCD measurements of V MCA nor plasma levels of nitrite/nitrate. Although the use of TCD is hampered by large measurement variation, it still predicts mortality after SAH. 31 V MCA in SAH subjects is inversely correlated to plasma levels of nitrite/nitrate and to the 894G/G genotype of the NOS3 gene, but not to arginine, ADMA, or arginine:ADMA ratio. 12 30 32 Thus, flow and diameter changes in large cerebral conductance vessels, as reflected by V MCA , might be primarily governed by the nitrite/nitrate pathway, whereas changes on a microvascular level, as reflected by RHI, are more reliant on the arginine/ADMA pathway. 12 26 Further studies are needed to evaluate the RHI response to arginine and nitric oxide donors in aneurysmal SAH. Plasma concentration of S-100B is associated with outcome after SAH. 33 Consistent with this, we found that S-100B was significantly higher in non-survivors and in subjects with neurological deficit. At the same time, S-100B decreased successively in subjects surviving to day 30. Thus, the well-known association of circulating levels of S-100B with cerebral vasospasm and outcome was fully reproduced in this study. The lack of any association between values of RHI and S-100B, and of a significant association between RHI and clinical variables as well, does not favour the use of RHI as an overall outcome marker in aneurysmal SAH. There are several limitations to the present study. First, the sample size in this single-centre study is too low to allow analysis of the predictive powerof PATmeasurements. Moreover, given the sample size and number of events, adjustments for further confounding factors are not possible. Secondly, a positive control group with the same incidences of smoking, alcohol abuse, and arterial hypertension as those present in the SAH population was not included. Thus, the degree of endothelial dysfunction before aneurysmal rupture remains unknown. Thirdly, in this observational study, no causal mechanism for the association of arginine/ADMA and RHI can be determined.
In conclusion, we found that endothelial function measured by PAT is impaired in the first days after SAH. Correlation of RHI with the arginine:ADMA ratio suggests that endothelial dysfunction after SAH is coupled to imbalance of the arginine/ ADMA pathway. PAT is a feasible technique in patients with SAH, and is relevant to study further in relation to therapeutic intervention and outcome.
